Glaukos Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to introduce our next company. It's going to be CEO, Tom Burns, presenting for Glaukos. Lots of news flow today from the company. I feel honored. It's like a mini analyst day they've provided the JPMorgan conference here.
So before we get to that, everyone can go to the conference website and follow along with the slide deck. You could submit a question there or you could e-mail me or chat me on Bloomberg, and I'll do my best to get to all the questions in Q&A. So with that, Tom, I'll turn it over to you.
Thank you very much, Robbie, and appreciate you having the access for the company today. I'm delighted to give an update on Glaukos Corporation and really want to talk about from the inception of this company, our mission has been to transform glaucoma therapy. And in doing so, we founded an entirely new
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
